(VIANEWS) – Trip.com (TCOM), STAAR Surgical Company (STAA), Catalyst Pharmaceuticals (CPRX) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Trip.com (TCOM)
23.6% sales growth and 9.16% return on equity
Trip.com Group Limited operates as a travel service provider for accommodation reservation, transportation ticketing, packaged tours and in-destination, corporate travel management, and other travel-related services in China and internationally. The company acts as an agent for hotel-related transactions and selling air tickets, as well as provides train, long-distance bus, and ferry tickets; travel insurance products, such as flight delay, air accident, and baggage loss coverage; and air-ticket delivery, online check-in and seat selection, express security screening, real-time flight status tracker, and airport VIP lounge services. It also provides independent leisure travelers bundled packaged-tour products comprising group, semi-group, and customized and packaged tours with various transportation arrangements, including air, cruise, bus, and car rental services. In addition, the company offers integrated transportation and accommodation services; destination transportation and ticket, activity, insurance, visa, and tour guide services; user support, supplier management, and customer relationship management services; and in-destination products and services. Further, it provides its corporate clients with business visit, incentive trip, meeting and conference, travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information management, online booking and authorization, online inquiry, and travel reporting systems. Additionally, the company offers online advertising and financial services. It operates under the Ctrip, Qunar, Trip.com, and Skyscanner brands. The company was formerly known as Ctrip.com International, Ltd. and changed its name to Trip.com Group Limited in October 2019. Trip.com Group Limited was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Trip.com has a trailing twelve months EPS of $1.34.
PE Ratio
Trip.com has a trailing twelve months price to earnings ratio of 26.38. Meaning, the purchaser of the share is investing $26.38 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.16%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Trip.com’s EBITDA is 15.17.
Moving Average
Trip.com’s value is above its 50-day moving average of $34.44 and below its 200-day moving average of $35.93.
2. STAAR Surgical Company (STAA)
19.4% sales growth and 5.57% return on equity
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Earnings Per Share
As for profitability, STAAR Surgical Company has a trailing twelve months EPS of $0.38.
PE Ratio
STAAR Surgical Company has a trailing twelve months price to earnings ratio of 88.71. Meaning, the purchaser of the share is investing $88.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.57%.
3. Catalyst Pharmaceuticals (CPRX)
19.3% sales growth and 20.06% return on equity
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Earnings Per Share
As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.55.
PE Ratio
Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 25.24. Meaning, the purchaser of the share is investing $25.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.06%.
4. Agree Realty Corporation (ADC)
17.8% sales growth and 3.38% return on equity
Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of June 30, 2020, the Company owned and operated a portfolio of 936 properties, located in 46 states and containing approximately 18.4 million square feet of gross leasable area. The common stock of Agree Realty Corporation is listed on the New York Stock Exchange under the symbol "ADC".
Earnings Per Share
As for profitability, Agree Realty Corporation has a trailing twelve months EPS of $1.7.
PE Ratio
Agree Realty Corporation has a trailing twelve months price to earnings ratio of 33.32. Meaning, the purchaser of the share is investing $33.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.38%.
Volume
Today’s last reported volume for Agree Realty Corporation is 714573 which is 15.75% below its average volume of 848209.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 29, 2023, the estimated forward annual dividend rate is 2.96 and the estimated forward annual dividend yield is 5.23%.
5. Ituran Location and Control Ltd. (ITRN)
14.5% sales growth and 29.44% return on equity
Ituran Location and Control Ltd., together with its subsidiaries, provides location-based services and wireless communications products. The company's Location-Based Services segment provides stolen vehicle recovery and tracking services, which locate, track, and recover stolen vehicles for its subscribers; fleet management services that enable corporate and individual customers to track and manage their vehicles in real time; and personal locator services that allow customers to protect valuable merchandise and equipment. It also offers on-demand navigation guidance, information, and assistance, including the provision of traffic reports and directions, as well as information on the location of gas stations, car repair shops, post offices, hospitals, and other facilities; and Connected Car, service platform includes a back-office application, a telematics device installed in the vehicle, mobile apps for both IOS and Android users, as well as usage based insurance. This segment serves insurance companies and agents, car manufacturers, dealers and importers, cooperative sales channels, and private subscribers. Its Wireless Communications Products segment provides Base Site, a radio receiver that includes a processor and a data computation unit to collect and send data to and from transponders, and to control centers; Control Center, a center consisting of software used to collect data from various base sites, conduct location calculations, and transmit location data to various customers and law enforcement agencies; navigation and tracking devices installed in vehicles; and SMART, a portable transmitter installed in vehicles that sends a signal to the base site enabling the location of vehicles, equipment, or an individual. As of December 31, 2020, it served approximately 17,680,000 end-users in Israel, Brazil, Argentina, Mexico, Ecuador, Colombia, and the United States. The company was incorporated in 1994 and is headquartered in Azor, Israel.
Earnings Per Share
As for profitability, Ituran Location and Control Ltd. has a trailing twelve months EPS of $2.14.
PE Ratio
Ituran Location and Control Ltd. has a trailing twelve months price to earnings ratio of 11.52. Meaning, the purchaser of the share is investing $11.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 29.44%.
6. AptarGroup (ATR)
6.6% sales growth and 13.72% return on equity
AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active packaging products. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. The company was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Earnings Per Share
As for profitability, AptarGroup has a trailing twelve months EPS of $4.21.
PE Ratio
AptarGroup has a trailing twelve months price to earnings ratio of 29.86. Meaning, the purchaser of the share is investing $29.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.72%.
Volume
Today’s last reported volume for AptarGroup is 195598 which is 37.71% below its average volume of 314015.
Earnings Before Interest, Taxes, Depreciation, and Amortization
AptarGroup’s EBITDA is 2.71.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 33.7% and 20.7%, respectively.
Previous days news about AptarGroup(ATR)
- Aptargroup (atr) up 4.2% since last earnings report: can it continue?. According to Zacks on Friday, 24 November, "A month has gone by since the last earnings report for AptarGroup (ATR Quick QuoteATR – Free Report) . ", "Will the recent positive trend continue leading up to its next earnings release, or is AptarGroup due for a pullback? "
7. Betterware de Mexico, S.A.P.I de C.V. (BWMX)
5.8% sales growth and 80.96% return on equity
Betterware de México, S.A.P.I. de C.V. operates as a direct-to-consumer company. It operates through two segments, The Home Organization Products (Betterware or BWM); and The Beauty and Personal Care Products (JAFRA). The Betterware or BWM segment provides a portfolio of products comprising kitchen and food preservation; home solutions; bedroom; bathroom; laundry and cleaning; and technology and mobility. The JAFRA segment offers beauty and personal care products, such as fragrances; colors comprising cosmetics; skin care products; and toiletries. Betterware de México, S.A.P.I. de C.V. sells its products through catalogues, as well as distributes through a network of distributors, associates, leaders, and consultants to the end customers in Mexico and the United States. The company is headquartered in El Arenal, Mexico. Betterware de México, S.A.P.I. de C.V. is a subsidiary of Ebc Holdings, Inc.
Earnings Per Share
As for profitability, Betterware de Mexico, S.A.P.I de C.V. has a trailing twelve months EPS of $1.39.
PE Ratio
Betterware de Mexico, S.A.P.I de C.V. has a trailing twelve months price to earnings ratio of 10.57. Meaning, the purchaser of the share is investing $10.57 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 80.96%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 15, 2023, the estimated forward annual dividend rate is 0.67 and the estimated forward annual dividend yield is 4.59%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 9.7% and positive 16.7% for the next.
